Logo
INSULIN GLARGINE MARKET ANALYSIS
  2. / Market Insights
  3. Insulin Glargine Market Analysis
all report title image

INSULIN GLARGINE MARKET ANALYSIS

Insulin Glargine Market, By Type (Lantus, Basaglar, Toujeo, Soliqua/Suliqua, Others), By Diabetes Type (Type 2 Diabetes, Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Mar 2024
  • Code : CMI5231
  • Pages :167
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Insulin Glargine Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Sanofi
  • Biocon
  • Eli Lilly and Company
  • Boehringer Ingelheim
  • Gan & Lee
  • Kalbe Pharma
  • Polus Biopharm
  • Samsung Bioepis
  • Wockhardt
  • Novo Nordisk AS
  • Julphar
  • Viatris Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

The Insulin Glargine Market is estimated to be valued at USD 5.45 billion in 2024.
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.